Risk Factors Associated With Chronic Liver Enzyme Elevation in Persons With HIV Without Hepatitis B or C Coinfection in the Combination Antiretroviral Therapy Era
Shannon M. Wood(Madigan Army Medical Center), Anuradha Ganesan(Walter Reed National Military Medical Center), Tahaniyat Lalani(Henry M. Jackson Foundation), Christina Schofield(Madigan Army Medical Center), Ryan C. Maves(Naval Medical Center San Diego), Rhonda E Colombo(Henry M. Jackson Foundation), Karl Kronmann(Naval Medical Center Portsmouth), Seung Won(Henry M. Jackson Foundation), Jason M Blaylock, Jason F. Okulicz(Gilead Sciences (United States)), Brian K. Agan(Henry M. Jackson Foundation), Hsing-Chuan Hsieh(Henry M. Jackson Foundation), Gregory Utz(Henry M. Jackson Foundation)
Cited by 12
Related Papers
Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza
|BMC Infectious Diseases|2015|514
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
|New England Journal of Medicine|2013|358
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study
|The Journal of Infectious Diseases|2009|305
Cohort Study of Molecular Identification and Typing of <i>Mycobacterium abscessus, Mycobacterium massiliense</i> , and <i>Mycobacterium bolletii</i>
|Journal of Clinical Microbiology|2009|221
Invasive Mold Infections Following Combat-related Injuries
|Clinical Infectious Diseases|2012|191